| |
| |
|
| Insider
Information: |
Auerbach Mark |
| Relationship: |
Director |
| City: |
Spring Valley |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
1,864,435 |
|
|
Indirect Shares
|
1,885,956 |
|
|
| Direct
Value |
$142 |
|
|
|
Indirect Value
|
$33 |
|
|
| Total
Shares |
3,750,391 |
|
|
| Total
Value |
$174 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Par Pharmaceutical Companies Inc |
PRX |
Executive Chairman, Di... |
2006-01-09 |
35,730 |
2004-05-06 |
0 |
Premium* |
|
|
Neuro-Hitech Pharmaceuticals Inc |
NHPI |
Director |
2008-06-24 |
300,000 |
2008-06-24 |
602,623 |
Premium* |
|
|
Rxelite Inc |
RXEI |
Director |
2008-06-04 |
1,416,666 |
2007-07-13 |
316,666 |
Premium* |
|
|
Optimer Pharmaceuticals Inc |
OPTR |
Director |
2013-10-24 |
0 |
2007-09-12 |
0 |
Premium* |
|
|
Collexis Holdings Inc |
CLXS |
Director |
|
0 |
2008-07-07 |
966,667 |
Premium* |
|
|
RCS Capital Corp |
RCAP |
Director |
2015-12-18 |
112,039 |
2014-06-05 |
0 |
Premium* |
|
|
Pardes Biosciences Ord Shs |
PRDS |
Director |
2023-08-31 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRDS |
Pardes Biosciences Ord Sh... |
Director |
– • – |
2023-08-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(70,390) |
0 |
0 |
- |
|
| PRDS |
Pardes Biosciences Ord Sh... |
Director |
– • – |
2021-12-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
70,390 |
|
% |
|
| RCAP |
RCS Capital Corp |
Director |
– • – |
2015-12-18 |
4 |
D |
$11.21 |
$229,472 |
D/D |
(20,346) |
112,039 |
0 |
- |
|
| RCAP |
RCS Capital Corp |
Director |
– • – |
2015-08-18 |
4 |
A |
$2.52 |
$249,999 |
D/D |
99,206 |
132,385 |
0 |
- |
|
| RCAP |
RCS Capital Corp |
Director |
– • – |
2015-01-13 |
4 |
A |
$11.21 |
$229,472 |
D/D |
20,346 |
33,179 |
0 |
- |
|
| RCAP |
RCS Capital Corp |
Director |
– • – |
2014-06-09 |
4 |
A |
$21.00 |
$264,525 |
D/D |
11,833 |
12,833 |
0 |
- |
|
| RCAP |
RCS Capital Corp |
Director |
– • – |
2014-06-05 |
4 |
B |
$20.20 |
$20,200 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2013-10-24 |
4 |
D |
$10.75 |
$215,000 |
D/D |
(20,000) |
0 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2013-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
20,000 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2013-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
17,500 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2012-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
10,000 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2012-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
7,500 |
0 |
- |
|
| CLXS |
Collexis Holdings Inc |
Director |
– • – |
2008-07-07 |
4 |
A |
$0.15 |
$100,000 |
I/I |
666,667 |
966,667 |
0 |
- |
|
| NHPI |
Neuro-Hitech Pharmaceutic... |
Director |
– • – |
2008-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
300,000 |
0 |
- |
|
| NHPI |
Neuro-Hitech Pharmaceutic... |
Director |
– • – |
2008-06-06 |
4 |
B |
$0.25 |
$100,000 |
I/I |
400,000 |
602,623 |
2.1 |
- |
|
| RXEI |
Rxelite Inc |
Director |
– • – |
2008-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,100,000 |
1,416,666 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2007-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
0 |
- |
|
| RXEI |
Rxelite Inc |
Director |
– • – |
2007-07-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
316,666 |
|
- |
|
| CLXS |
Collexis Holdings Inc |
Director |
– • – |
2007-06-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
300,000 |
|
- |
|
| NHPI |
Neuro-Hitech Pharmaceutic... |
Director |
– • – |
2006-10-06 |
5 |
A |
$6.36 |
$3,002 |
I/I |
472 |
202,623 |
0 |
- |
|
| NHPI |
Neuro-Hitech Pharmaceutic... |
Director |
– • – |
2006-09-06 |
5 |
A |
$6.21 |
$2,999 |
I/I |
483 |
202,151 |
0 |
- |
|
| NHPI |
Neuro-Hitech Pharmaceutic... |
Director |
– • – |
2006-08-07 |
5 |
A |
$6.12 |
$2,999 |
I/I |
490 |
201,668 |
0 |
- |
|
| NHPI |
Neuro-Hitech Pharmaceutic... |
Director |
– • – |
2006-07-06 |
5 |
A |
$7.48 |
$2,999 |
I/I |
401 |
201,178 |
0 |
- |
|
| NHPI |
Neuro-Hitech Pharmaceutic... |
Director |
– • – |
2006-06-06 |
5 |
A |
$7.45 |
$3,002 |
I/I |
403 |
200,777 |
0 |
- |
|
| NHPI |
Neuro-Hitech Pharmaceutic... |
Director |
– • – |
2006-05-08 |
5 |
A |
$8.03 |
$3,003 |
I/I |
374 |
200,374 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
